OnKure Therapeutics, Inc. (OKUR): Free Cash Flow
-$51.87M
Year ended 2025-12-31
-$47.86M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$51.87M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$51.17M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$34.79M | n/c | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | -$47.71M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$38.18M | n/m | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | -$18.56M | n/a | 2022-03-23, From 2020-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | 2025-12-31 | -$51.87M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $6.67M | -36.5% |
| Rallybio Corp (RLYB) | 2024-12-31 | -$49.28M | n/m |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | -$33.54M | n/m |
| DiaMedica Therapeutics Inc. (DMAC) | 2025-12-31 | -$29.10M | n/m |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | -$8.34M | n/m |
| ALX Oncology Holdings Inc (ALXO) | 2025-12-31 | -$84.35M | n/m |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | -$18.80M | n/m |
| Biomea Fusion, Inc. (BMEA) | 2024-12-31 | -$120.26M | n/m |
Compare OKUR, LFVN, RLYB, QTTB side by side · Screen every company in Pharmaceutical Preparations ↗